 |
Dermagraft |
|---|---|
| Trade Name | |
| Orphan Indication | Dystrophic epidermolysis bullosa |
| USA Market Approval | USA |
| USA Designation Date | 2010-12-13 00:00:00 |
| Sponsor | Shire Regenerative Medicine, Inc.;11095 Torreyana Road, subsidiary of Shire Pharmaceuticals.;San Diego, California, 92121 |
